(Q37767654)

22 August 2017

1 reference

title

Potential of carbohydrate-binding agents as therapeutics against enveloped viruses (English)

1 reference

22 August 2017

K O François

1

1 reference

PubMed ID

20577974

22 August 2017

J Balzarini

series ordinal

2

1 reference

22 August 2017

23 June 2010

1 reference

Medicinal Research Reviews

22 August 2017

1 reference

22 August 2017

32

1 reference

22 August 2017

2

1 reference

22 August 2017

349-387

1 reference

Inhibition of HIV entry by carbohydrate-binding proteins

22 August 2017

1 reference

Proteins that bind high-mannose sugars of the HIV envelope

21 January 2018

1 reference

Entry of hepatitis C virus and human immunodeficiency virus is selectively inhibited by carbohydrate-binding agents but not by polyanions

21 January 2018

1 reference

Cyanovirin-N inhibits hepatitis C virus entry by binding to envelope protein glycans

21 January 2018

1 reference

Antiviral activity of carbohydrate-binding agents and the role of DC-SIGN in dengue virus infection

21 January 2018

1 reference

Plant lectins are potent inhibitors of coronaviruses by interfering with two targets in the viral replication cycle

21 January 2018

1 reference

Antiviral activity of carbohydrate-binding agents against Nidovirales in cell culture

21 January 2018

1 reference

Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR

21 January 2018

1 reference

Human occludin is a hepatitis C virus entry factor required for infection of mouse cells

21 January 2018

1 reference

Biogenesis of hepatitis C virus envelope glycoproteins

21 January 2018

1 reference

Analysis of the glycosylation sites of hepatitis C virus (HCV) glycoprotein E1 and the influence of E1 glycans on the formation of the HCV glycoprotein complex.

21 January 2018

1 reference

Mass spectrometric characterization of glycosylation of hepatitis C virus E2 envelope glycoprotein reveals extended microheterogeneity of N-glycans

21 January 2018

1 reference

Functional domains within the human immunodeficiency virus type 2 envelope protein required to enhance virus production

21 January 2018

1 reference

Mutagenesis of the fusion peptide-like domain of hepatitis C virus E1 glycoprotein: involvement in cell fusion and virus entry

21 January 2018

1 reference

21 January 2018

1 reference

A structural perspective of the flavivirus life cycle

21 January 2018

1 reference

Closing the door on flaviviruses: Entry as a target for antiviral drug design

21 January 2018

1 reference

Dengue virus envelope glycoprotein structure: New insight into its interactions during viral entry

21 January 2018

1 reference

N-linked glycans on dengue viruses grown in mammalian and insect cells

21 January 2018

1 reference

Determination of N-glycosylation site and glycan structures of pectin methylesterase in jelly fig (Ficus awkeotsang) Achenes.

21 January 2018

1 reference

The spike protein of SARS-CoV--a target for vaccine and therapeutic development

21 January 2018

1 reference

Studies on membrane topology, N-glycosylation and functionality of SARS-CoV membrane protein

21 January 2018

1 reference

Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin

21 January 2018

1 reference

The HTLV-I envelope glycoproteins: structure and functions

21 January 2018

1 reference

Viral entry mechanisms: cellular and viral mediators of herpes simplex virus entry

21 January 2018

1 reference

Understanding HSV-1 entry glycoproteins.

21 January 2018

1 reference

Herpes simplex virus: receptors and ligands for cell entry

21 January 2018

1 reference

Characterization of two different human cytomegalovirus glycoproteins which are targets for virus neutralizing antibody

21 January 2018

1 reference

The mannose-specific plant lectins from Cymbidium hybrid and Epipactis helleborine and the (N-acetylglucosamine)n-specific plant lectin from Urtica dioica are potent and selective inhibitors of human immunodeficiency virus and cytomegalovirus replic

21 January 2018

1 reference

Solution structure of a cyanovirin-N:Man alpha 1-2Man alpha complex: structural basis for high-affinity carbohydrate-mediated binding to gp120

21 January 2018

1 reference

Crystal structure of cyanovirin-N, a potent HIV-inactivating protein, shows unexpected domain swapping

21 January 2018

1 reference

Treatment of influenza A (H1N1) virus infections in mice and ferrets with cyanovirin-N.

21 January 2018

1 reference

Cyanovirin-N binds to the viral surface glycoprotein, GP1,2 and inhibits infectivity of Ebola virus

21 January 2018

1 reference

The highly specific carbohydrate-binding protein cyanovirin-N: structure, anti-HIV/Ebola activity and possibilities for therapy

21 January 2018

1 reference

A sugar binding protein cyanovirin-N blocks herpes simplex virus type-1 entry and cell fusion

21 January 2018

1 reference

Cyanovirin-N inhibits AIDS virus infections in vaginal transmission models

21 January 2018

1 reference

Engineered vaginal lactobacillus strain for mucosal delivery of the human immunodeficiency virus inhibitor cyanovirin-N

21 January 2018

1 reference

Bioengineering lactic acid bacteria to secrete the HIV-1 virucide cyanovirin

21 January 2018

1 reference

Isolation and characterization of a mannan-binding lectin from the freshwater cyanobacterium (blue-green algae) Microcystis viridis.

21 January 2018

1 reference

Crystal structures of the HIV-1 inhibitory cyanobacterial protein MVL free and bound to Man3GlcNAc2: structural basis for specificity and high-affinity binding to the core pentasaccharide from n-linked oligomannoside

21 January 2018

1 reference

A potent novel anti-HIV protein from the cultured cyanobacterium Scytonema varium

21 January 2018

1 reference

Potent anti-HIV activity of scytovirin domain 1 peptide.

21 January 2018

1 reference

Primary structure and carbohydrate binding specificity of a potent anti-HIV lectin isolated from the filamentous cyanobacterium Oscillatoria agardhii

21 January 2018

1 reference

Actinohivin, a novel anti-HIV protein from an actinomycete that inhibits syncytium formation: isolation, characterization, and biological activities

21 January 2018

1 reference

Actinohivin, a novel anti-human immunodeficiency virus protein from an actinomycete, inhibits viral entry to cells by binding high-mannose type sugar chains of gp120.

21 January 2018

1 reference

Mechanism by which the lectin actinohivin blocks HIV infection of target cells

21 January 2018

1 reference

Isolation and characterization of griffithsin, a novel HIV-inactivating protein, from the red alga Griffithsia sp

21 January 2018

1 reference

Griffithsin, a potent HIV entry inhibitor, is an excellent candidate for anti-HIV microbicide

21 January 2018

1 reference

Scaleable manufacture of HIV-1 entry inhibitor griffithsin and validation of its safety and efficacy as a topical microbicide component

21 January 2018

1 reference

Domain-swapped structure of the potent antiviral protein griffithsin and its mode of carbohydrate binding.

21 January 2018

1 reference

Alpha-(1-3)- and alpha-(1-6)-D-mannose-specific plant lectins are markedly inhibitory to human immunodeficiency virus and cytomegalovirus infections in vitro

21 January 2018

1 reference

Isolation and characterization of Myrianthus holstii lectin, a potent HIV-1 inhibitory protein from the plant Myrianthus holstii(1).

21 January 2018

1 reference

Targeting the glycans of glycoproteins: a novel paradigm for antiviral therapy

21 January 2018

1 reference

Role of envelope glycoprotein carbohydrate in human immunodeficiency virus (HIV) infectivity and virus-induced cell fusion

21 January 2018

1 reference

A lectin isolated from bananas is a potent inhibitor of HIV replication

21 January 2018

1 reference

A beta-galactose-specific lectin isolated from the marine worm Chaetopterus variopedatus possesses anti-HIV-1 activity

21 January 2018

1 reference

A new lectin from the sea worm Serpula vermicularis: isolation, characterization and anti-HIV activity

21 January 2018

1 reference

C-type lectin Mermaid inhibits dendritic cell mediated HIV-1 transmission to CD4+ T cells

21 January 2018

1 reference

The C-type lectin superfamily in the immune system

21 January 2018

1 reference

Galectin-1 acts as a soluble host factor that promotes HIV-1 infectivity through stabilization of virus attachment to host cells

21 January 2018

1 reference

Protein-glycan interactions in the control of innate and adaptive immune responses

21 January 2018

1 reference

Invasive chronic inflammatory monocyte phenotype in subjects with high HIV-1 viral load

21 January 2018

1 reference

Sialoadhesin (CD169) expression in CD14+ cells is upregulated early after HIV-1 infection and increases during disease progression

21 January 2018

1 reference

Sialoadhesin expressed on IFN-induced monocytes binds HIV-1 and enhances infectivity

21 January 2018

1 reference

Myeloid C-type lectins in innate immunity

21 January 2018

1 reference

C-type lectin receptors on dendritic cells and Langerhans cells

21 January 2018

1 reference

Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses

21 January 2018

1 reference

DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells

21 January 2018

1 reference

DC-SIGN interactions with human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus

21 January 2018

1 reference

Structural basis for selective recognition of oligosaccharides by DC-SIGN and DC-SIGNR

21 January 2018

1 reference

Cutting edge: carbohydrate profiling identifies new pathogens that interact with dendritic cell-specific ICAM-3-grabbing nonintegrin on dendritic cells

21 January 2018

1 reference

cis Expression of DC-SIGN allows for more efficient entry of human and simian immunodeficiency viruses via CD4 and a coreceptor

21 January 2018

1 reference

DC-SIGN on B lymphocytes is required for transmission of HIV-1 to T lymphocytes

21 January 2018

1 reference

The role of DC-SIGN and DC-SIGNR in HIV and SIV attachment, infection, and transmission.

21 January 2018

1 reference

Cell type-dependent retention and transmission of HIV-1 by DC-SIGN.

21 January 2018

1 reference

Immunodeficiency virus uptake, turnover, and 2-phase transfer in human dendritic cells.

21 January 2018

1 reference

Viral piracy: HIV-1 targets dendritic cells for transmission

21 January 2018

1 reference

Transmission of macrophage-tropic HIV-1 by breast-milk macrophages via DC-SIGN.

21 January 2018

1 reference

Breastfeeding to prevent HIV transmission in infants: balancing pros and cons

21 January 2018

1 reference

Lewis X component in human milk binds DC-SIGN and inhibits HIV-1 transfer to CD4+ T lymphocytes

21 January 2018

1 reference

Bile salt-stimulated lipase from human milk binds DC-SIGN and inhibits human immunodeficiency virus type 1 transfer to CD4+ T cells

21 January 2018

1 reference

MUC1 in human milk blocks transmission of human immunodeficiency virus from dendritic cells to T cells

21 January 2018

1 reference

Inhibition of HIV-1 transmission in trans from dendritic cells to CD4+ T lymphocytes by natural antibodies to the CRD domain of DC-SIGN purified from breast milk and intravenous immunoglobulins

21 January 2018

1 reference

21 January 2018

1 reference

DC-SIGNR, a DC-SIGN homologue expressed in endothelial cells, binds to human and simian immunodeficiency viruses and activates infection in trans

21 January 2018

1 reference

L-SIGN (CD 209L) is a liver-specific capture receptor for hepatitis C virus

21 January 2018

1 reference

DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and the S protein of severe acute respiratory syndrome coronavirus

21 January 2018

1 reference

DC-SIGN and DC-SIGNR bind ebola glycoproteins and enhance infection of macrophages and endothelial cells.

21 January 2018

1 reference

C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans

21 January 2018

1 reference

Dendritic-cell-specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue viruses

21 January 2018

1 reference

DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells

21 January 2018

1 reference

DC-SIGN mediates cell-free infection and transmission of human T-cell lymphotropic virus type 1 by dendritic cells

21 January 2018

1 reference

Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules

21 January 2018

1 reference

Characterization of carbohydrate recognition by langerin, a C-type lectin of Langerhans cells

21 January 2018

1 reference

The carbohydrate recognition domain of Langerin reveals high structural similarity with the one of DC-SIGN but an additional, calcium-independent sugar-binding site

21 January 2018

1 reference

R5 HIV productively infects Langerhans cells, and infection levels are regulated by compound CCR5 polymorphisms

21 January 2018

1 reference

Langerin is a natural barrier to HIV-1 transmission by Langerhans cells

21 January 2018

1 reference

Activated CD34-derived Langerhans cells mediate transinfection with human immunodeficiency virus

21 January 2018

1 reference

Inhibiting sexual transmission of HIV-1 infection

21 January 2018

1 reference

HIV binding, penetration, and primary infection in human cervicovaginal tissue

21 January 2018

1 reference

Parameters of human immunodeficiency virus infection of human cervical tissue and inhibition by vaginal virucides

21 January 2018

1 reference

Role of the mannose receptor in the immune response

21 January 2018

1 reference

The mannose receptor is a pattern recognition receptor involved in host defense

21 January 2018

1 reference

Involvement of macrophage mannose receptor in the binding and transmission of HIV by macrophages

21 January 2018

1 reference

Oligomerization of the macrophage mannose receptor enhances gp120-mediated binding of HIV-1.

21 January 2018

1 reference

Noninfectious entry of HIV-1 into peripheral and brain macrophages mediated by the mannose receptor

21 January 2018

1 reference

The serum mannose-binding protein and the macrophage mannose receptor are pattern recognition molecules that link innate and adaptive immunity

21 January 2018

1 reference

Mannose-binding lectin: targeting the microbial world for complement attack and opsonophagocytosis

21 January 2018

1 reference

Structural basis of lectin-carbohydrate recognition

21 January 2018

1 reference

A novel mechanism of carbohydrate recognition by the C-type lectins DC-SIGN and DC-SIGNR. Subunit organization and binding to multivalent ligands

21 January 2018

1 reference

Self- and nonself-recognition by C-type lectins on dendritic cells

21 January 2018

1 reference

A human serum mannose-binding protein inhibits in vitro infection by the human immunodeficiency virus

21 January 2018

1 reference

Interaction of mannose-binding lectin with primary isolates of human immunodeficiency virus type 1

21 January 2018

1 reference

Interaction of mannose-binding lectin with HIV type 1 is sufficient for virus opsonization but not neutralization

21 January 2018

1 reference

Complement activation upon binding of mannan-binding protein to HIV envelope glycoproteins

21 January 2018

1 reference

Localization of lung surfactant protein D on mucosal surfaces in human tissues

21 January 2018

1 reference

Heritability estimates for the constitutional levels of the collectins mannan-binding lectin and lung surfactant protein D. A study of unselected like-sexed mono- and dizygotic twins at the age of 6-9 years.

21 January 2018

1 reference

Surfactant protein D binds to human immunodeficiency virus (HIV) envelope protein gp120 and inhibits HIV replication

21 January 2018

1 reference

Surfactant protein A binds to HIV and inhibits direct infection of CD4+ cells, but enhances dendritic cell-mediated viral transfer

21 January 2018

1 reference

The C-type lectin surface receptor DCIR acts as a new attachment factor for HIV-1 in dendritic cells and contributes to trans- and cis-infection pathways

21 January 2018

1 reference

The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120.

21 January 2018

1 reference

The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1-->2 mannose residues on the outer face of gp120.

21 January 2018

1 reference

Antibody domain exchange is an immunological solution to carbohydrate cluster recognition

21 January 2018

1 reference

A glycoconjugate antigen based on the recognition motif of a broadly neutralizing human immunodeficiency virus antibody, 2G12, is immunogenic but elicits antibodies unable to bind to the self glycans of gp120

21 January 2018

1 reference

An oligosaccharide-based HIV-1 2G12 mimotope vaccine induces carbohydrate-specific antibodies that fail to neutralize HIV-1 virions

21 January 2018

1 reference

A yeast glycoprotein shows high-affinity binding to the broadly neutralizing human immunodeficiency virus antibody 2G12 and inhibits gp120 interactions with 2G12 and DC-SIGN.

21 January 2018

1 reference

An engineered Saccharomyces cerevisiae strain binds the broadly neutralizing human immunodeficiency virus type 1 antibody 2G12 and elicits mannose-specific gp120-binding antibodies

21 January 2018

1 reference

Novel template-assembled oligosaccharide clusters as epitope mimics for HIV-neutralizing antibody 2G12. Design, synthesis, and antibody binding study

21 January 2018

1 reference

Targeting the carbohydrates on HIV-1: Interaction of oligomannose dendrons with human monoclonal antibody 2G12 and DC-SIGN

21 January 2018

1 reference

Defensins: antimicrobial and cytotoxic peptides of mammalian cells

21 January 2018

1 reference

Gallinacin-3, an inducible epithelial beta-defensin in the chicken

21 January 2018

1 reference

Defensins of vertebrate animals

21 January 2018

1 reference

Retrocyclin: a primate peptide that protects cells from infection by T- and M-tropic strains of HIV-1.

21 January 2018

1 reference

The θ-Defensin, Retrocyclin, Inhibits HIV-1 Entry

21 January 2018

1 reference

Retrocyclin, an Antiretroviral θ-Defensin, Is a Lectin

21 January 2018

1 reference

Activity of alpha- and theta-defensins against primary isolates of HIV-1

21 January 2018

1 reference

Cutting edge: human beta defensin 3--a novel antagonist of the HIV-1 coreceptor CXCR4.

21 January 2018

1 reference

Compounds active against cell walls of medically important fungi

21 January 2018

1 reference

Pradimicin A, a carbohydrate-binding nonpeptidic lead compound for treatment of infections with viruses with highly glycosylated envelopes, such as human immunodeficiency virus

21 January 2018

1 reference

Pradimicin S, a highly soluble nonpeptidic small-size carbohydrate-binding antibiotic, is an anti-HIV drug lead for both microbicidal and systemic use.

21 January 2018

1 reference

The phthalocyanine prototype derivative Alcian Blue is the first synthetic agent with selective anti-human immunodeficiency virus activity due to its gp120 glycan-binding potential

21 January 2018

1 reference

Targeting glycosylation as a therapeutic approach

21 January 2018

1 reference

N-Butyldeoxynojirimycin is a broadly effective anti-HIV therapy significantly enhanced by targeted liposome delivery

21 January 2018

1 reference

The alpha(1,2)-mannosidase I inhibitor 1-deoxymannojirimycin potentiates the antiviral activity of carbohydrate-binding agents against wild-type and mutant HIV-1 strains containing glycan deletions in gp120.

21 January 2018

1 reference

Inhibitors against glycosidases as medicines

21 January 2018

1 reference

Natural and synthetic iminosugars as carbohydrate processing enzyme inhibitors for cancer therapy

21 January 2018

1 reference

Sustained therapeutic effects of oral miglustat (Zavesca, N-butyldeoxynojirimycin, OGT 918) in type I Gaucher disease.

21 January 2018

1 reference

New approaches to influenza chemotherapy. Neuraminidase inhibitors

21 January 2018

1 reference

Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis

21 January 2018

1 reference

Gold manno-glyconanoparticles: multivalent systems to block HIV-1 gp120 binding to the lectin DC-SIGN.

21 January 2018

1 reference

Glycodendritic structures: promising new antiviral drugs.

21 January 2018

1 reference

Profile of resistance of human immunodeficiency virus to mannose-specific plant lectins

21 January 2018

1 reference

Carbohydrate-binding agents efficiently prevent dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN)-directed HIV-1 transmission to T lymphocytes

21 January 2018

1 reference

Sugar-binding proteins potently inhibit dendritic cell human immunodeficiency virus type 1 (HIV-1) infection and dendritic-cell-directed HIV-1 transfer

21 January 2018

1 reference

Capture and transmission of HIV-1 by the C-type lectin L-SIGN (DC-SIGNR) is inhibited by carbohydrate-binding agents and polyanions

21 January 2018

1 reference

Carbohydrate-binding molecules inhibit viral fusion and entry by crosslinking membrane glycoproteins

21 January 2018

1 reference

Marked depletion of glycosylation sites in HIV-1 gp120 under selection pressure by the mannose-specific plant lectins of Hippeastrum hybrid and Galanthus nivalis.

21 January 2018

1 reference

Mutational pathways, resistance profile, and side effects of cyanovirin relative to human immunodeficiency virus type 1 strains with N-glycan deletions in their gp120 envelopes

21 January 2018

1 reference

Resistance of human immunodeficiency virus type 1 to the high-mannose binding agents cyanovirin N and concanavalin A.

21 January 2018

1 reference

A role for carbohydrates in immune evasion in AIDS.

21 January 2018

1 reference

High-mannose-specific deglycosylation of HIV-1 gp120 induced by resistance to cyanovirin-N and the impact on antibody neutralization

21 January 2018

1 reference

Intracellular functions of N-linked glycans

21 January 2018

1 reference

Glycan deletions in the HIV-1 gp120 V1/V2 domain compromise viral infectivity, sensitize the mutant virus strains to carbohydrate-binding agents and represent a specific target for therapeutic intervention

21 January 2018

1 reference

N-Glycans in the gp120 V1/V2 domain of the HIV-1 strain NL4-3 are indispensable for viral infectivity and resistance against antibody neutralization

21 January 2018

1 reference

Antibodies against Manalpha1,2-Manalpha1,2-Man oligosaccharide structures recognize envelope glycoproteins from HIV-1 and SIV strains

21 January 2018

1 reference

The carbohydrate-binding plant lectins and the non-peptidic antibiotic pradimicin A target the glycans of the coronavirus envelope glycoproteins

21 January 2018

1 reference

Comparative evaluation of the activity of antivirals towards feline immunodeficiency virus in different cell culture systems

21 January 2018

1 reference

Inhibition of cell-to-cell transmission of human T-cell lymphotropic virus type 1 in vitro by carbohydrate-binding agents

21 January 2018

1 reference

Potent anti-influenza activity of cyanovirin-N and interactions with viral hemagglutinin

21 January 2018

1 reference

Structural characterization of the N-linked oligosaccharides derived from HIVgp120 expressed in lepidopteran cells

21 January 2018

1 reference

DC-SIGN is the major Mycobacterium tuberculosis receptor on human dendritic cells

21 January 2018

1 reference

The dendritic cell-specific C-type lectin DC-SIGN is a receptor for Schistosoma mansoni egg antigens and recognizes the glycan antigen Lewis x.

21 January 2018

1 reference

Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial

21 January 2018

1 reference

Mannose-specific plant lectins from the Amaryllidaceae family qualify as efficient microbicides for prevention of human immunodeficiency virus infection

21 January 2018

1 reference

In vitro and in vivo: the story of nonoxynol 9.

21 January 2018

1 reference

Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission

21 January 2018

1 reference

Disruption of tight junctions by cellulose sulfate facilitates HIV infection: model of microbicide safety

21 January 2018

1 reference

In vitro synergistic activity against CCR5-tropic HIV-1 with combinations of potential candidate microbicide molecules HHA, KRV2110 and enfuvirtide (T20).

21 January 2018

1 reference

Strong antimicrobial activity of Lactobacillus rhamnosus GG against Salmonella typhimurium is due to accumulation of lactic acid.

21 January 2018

1 reference

Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens

21 January 2018

1 reference

The microbicide cyanovirin-N expressed on the surface of commensal bacterium Streptococcus gordonii captures HIV-1.

21 January 2018

1 reference

The supportive role of complement in HIV pathogenesis

21 January 2018

1 reference

HIV and human complement: inefficient virolysis and effective adherence.

21 January 2018

1 reference

21 January 2018

1 reference

The potent IgG4-inducing antigen in banana is a mannose-binding lectin, BanLec-I

21 January 2018

1 reference

Mammalian glycosylation in immunity

21 January 2018

1 reference

Inhibition of human immunodeficiency virus infection by the lectin jacalin and by a derived peptide showing a sequence similarity with gp120.

21 January 2018

1 reference

Insights into a conformational epitope of Hev b 6.02 (hevein)

21 January 2018

1 reference

Crystal structures of Urtica dioica agglutinin and its complex with tri-N-acetylchitotriose

21 January 2018

1 reference

Structure of mannose-specific snowdrop (Galanthus nivalis) lectin is representative of a new plant lectin family

21 January 2018

1 reference

N-terminal substitutions in HIV-1 gp41 reduce the expression of non-trimeric envelope glycoproteins on the virus

21 January 2018

1 reference

Safety concerns for the potential use of cyanovirin-N as a microbicidal anti-HIV agent

21 January 2018

1 reference

Carbohydrate-binding Agents Cause Deletions of Highly Conserved Glycosylation Sites in HIV GP120

21 January 2018

1 reference

HIV-1 Nef-Induced Upregulation of DC-SIGN in Dendritic Cells Promotes Lymphocyte Clustering and Viral Spread

21 January 2018

1 reference

Specificity of DC-SIGN for mannose- and fucose-containing glycans

21 January 2018

1 reference

Human Cytomegalovirus Binding to DC-SIGN Is Required for Dendritic Cell Infection and Target Cell trans-Infection

21 January 2018

1 reference

θ-Defensins Prevent HIV-1 Env-mediated Fusion by Binding gp41 and Blocking 6-Helix Bundle Formation

21 January 2018

1 reference

Mannose hyperbranched dendritic polymers interact with clustered organization of DC-SIGN and inhibit gp120 binding

21 January 2018

1 reference

A D-mannose-specific lectin from Gerardia savaglia that inhibits nucleocytoplasmic transport of mRNA

21 January 2018

1 reference

12 December 2020

Galectin-1 promotes HIV-1 infectivity in macrophages through stabilization of viral adsorption

1 reference

12 December 2020

DC-SIGN-mediated internalization of HIV is required for trans-enhancement of T cell infection

1 reference

12 December 2020

Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells

1 reference

12 December 2020

Fully Synthetic Carbohydrate HIV Antigens Designed on the Logic of the 2G12 Antibody

1 reference

12 December 2020

Multivalent manno-glyconanoparticles inhibit DC-SIGN-mediated HIV-1 trans-infection of human T cells

1 reference

12 December 2020

Correlation between carbohydrate structures on the envelope glycoprotein gp120 of.HIV-1 and HIV-2 and syncytium inhibition with lectins

1 reference

12 December 2020

The vaginal microbial ecosystem and resistance to HIV

1 reference

12 December 2020

Functional analysis of cell surface-expressed hepatitis C virus E2 glycoprotein

1 reference

12 December 2020

Primary structure of the mannose receptor contains multiple motifs resembling carbohydrate-recognition domains

1 reference

12 December 2020

Microbicide offers no protection against HIV infection

1 reference

12 December 2020

Studies on the mode of antifungal action of pradimicin antibiotics. III. Spectrophotometric sequence analysis of the ternary complex formation of BMY-28864 with D-mannopyranoside and calcium

1 reference

12 December 2020

Purification and structural analysis of the novel glycoprotein allergen Cyn d 24, a pathogenesis-related protein PR-1, from Bermuda grass pollen

1 reference

12 December 2020

The monoclonal antibody DCGM4 recognizes Langerin, a protein specific of Langerhans cells, and is rapidly internalized from the cell surface

1 reference

12 December 2020

Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development

1 reference

12 December 2020

A source of glycosylated human T-cell lymphotropic virus type 1 envelope protein: expression of gp46 by the vaccinia virus/T7 polymerase system

1 reference

12 December 2020

DC-SIGN specifically recognizes Streptococcus pneumoniae serotypes 3 and 14

1 reference

12 December 2020

The D-mannose-specific lectin from Gerardia savaglia blocks binding of human immunodeficiency virus type I to H9 cells and human lymphocytes in vitro.

1 reference

12 December 2020

Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81.

1 reference

12 December 2020

Natural human antibodies to dietary lectins

1 reference

12 December 2020

Extrahepatic manifestations of hepatitis C virus infection

1 reference

12 December 2020

Natural antibodies to dietary proteins: the existence of natural antibodies to alliinase (Alliin lyase) and mannose-specific lectin from garlic (Allium sativum) in human serum

1 reference

12 December 2020

Synthesis of nonribosomal RNA by lymphocytes: a response to phytohemagglutinin treatment

1 reference

12 December 2020

Carbohydrates of influenza virus. Structural elucidation of the individual glycans of the FPV hemagglutinin by two-dimensional 1H n.m.r. and methylation analysis

1 reference

12 December 2020

In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity

1 reference

12 December 2020

Alpha-defensins block the early steps of HIV-1 infection: interference with the binding of gp120 to CD4.

1 reference

12 December 2020

New antifungal antibiotics, benanomicins A and B inhibit infection of T-cell with human immunodeficiency virus (HIV) and syncytium formation by HIV.

1 reference

12 December 2020

Inhibitory effect of new antibiotic, pradimincin A on infectivity, cytopathic effect and replication of human immunodeficiency virus in vitro

1 reference

12 December 2020

The alpha-glucosidase inhibitor N-butyldeoxynojirimycin inhibits human immunodeficiency virus entry at the level of post-CD4 binding

1 reference

12 December 2020

Cyanovirin-N gel as a topical microbicide prevents rectal transmission of SHIV89.6P in macaques

1 reference

12 December 2020

Mass spectrometric characterization of proteins from the SARS virus: a preliminary report

1 reference

12 December 2020

Oligosaccharides in the stem region maintain the influenza virus hemagglutinin in the metastable form required for fusion activity.

1 reference

12 December 2020

Targeting the glycans of gp120: a novel approach aimed at the Achilles heel of HIV

1 reference

12 December 2020

Identifiers

DOI

10.1002/MED.20216

1 reference

22 August 2017

1 reference

PubMed ID

20577974